FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Maternal & Child Health

Misoprostol Can Prevent Post-Partum Hemorrhage

22 Sep 2020

Maternal health is considered to be a core marker in the functioning of any public healthcare delivery system. Hemorrhage accounts for 40% of maternal deaths in India with Post-Partum Haemorrhage (PPH) being the major contributor. In this study, Misoprostol has been successfully used for home deliveries, where the use of oxytocin is not possible, to stop Post-Partum Haemorrhaging. This paper studies the implementation of a 'community-based advance distribution of Misoprostol program' by USAID’s VRIDDHI project in Himachal Pradesh. It also demarcates an operational framework for distributing and using Misoprostol in a community health system. With proven success, Misoprostol can be used as an intervention for reducing PPH incidence, which will have a significant impact on maternal deaths during home deliveries. This study can be used to model and implement Misoprostol usage in communities. 

To access this, click here.

PUBLISHED BY
BMC Pregnancy and Childbirth
YEAR OF PUBLISHING
2018
AUTHORS
Rakesh Parashar, et al.

Categories

For health workers

RELATED
CONTENT

For policymakers Report

Trends in Maternal Mortality - 2000 to 2017

Mapping progress towards the SDG goal of reducing maternal mortality by 2030.

by WHO 75 min read

Maternal & Child Health
For implementers Report

Maternal Health Among the Urban Poor - A Report Card

Research highlighting the status of maternal health among the urban poor.

by Swasti - The Health ... 20 min read

Maternal & Child Health
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst